Estimate Recalculated Jun 11, 2025 11:46AM EST
Tomer Kariv does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Keros Therapeutics, Inc., VBI Vaccines Inc/BC, LogicBio Therapeutics, Inc., 89bio, Inc., Eloxx Pharmaceuticals, Inc., and Arno Therapeutics, Inc.
Tomer Kariv's CIK is 0001568077
2018 was Tomer Kariv's most active year for acquiring shares with 3 total transactions. Tomer Kariv's most active month to acquire stocks was the month of May. 2019 saw Tomer Kariv paying a total of $0.00 for 230,869 shares, this is the most they've acquired in one year.
No data available
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!